Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KAT6A | Q92794 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23965620 | 0.86 | HIF1A (0.45) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL30168077 | 0.86 | HIF1A (0.45) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL23983965 | 0.86 | PKM (0.39) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL23965621 | 0.84 | ALDH1A1 (0.38) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL30214721 | 0.81 | HIF1A (0.41) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL28917435 | 0.80 | NPC1 (0.37) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL25224343 | 0.80 | NPC1 (0.37) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL30168064 | 0.80 | GAA (0.36) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL23965569 | 0.80 | GAA (0.36) | PKMNPC1RAB9ASMN1; SMN2KAT6A | |
| SCHEMBL30104137 | 0.80 | HIF1A (0.38) | PKMNPC1RAB9ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3903581-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS I | BASF SE (DE) | 2021-11-03 | — | — | EP | disclosed |